Skip to content

Clinical trials

Pancreatic Intraductal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Intraductal Neoplasms Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20092
20101
20141
20161
20193
20202
20212
20221
20231
20244
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12
Not yet recruiting5
Active, not recruiting4
Unknown status4
Completed3
Enrolling by invitation2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS San Raffaele3
H. Lee Moffitt Cancer Center and Research Institute2
Instituto Ecuatoriano de Enfermedades Digestivas2
National Cancer Institute (NCI)2
Sahlgrenska University Hospital2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Adenocyte, LLC1
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis1
Changhai Hospital1
China-Japan Friendship Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Intraductal Neoplasms32
Pancreatic Neoplasms13
Pancreatic Cyst6
Pancreatitis, Chronic4
Pancreatitis3
Adenoma, Islet Cell2
Cholangiocarcinoma2
Colorectal Neoplasms2
Cystadenoma, Serous2
Diabetes Mellitus2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.